Harrow HROW
NASDAQ HROW
$37.65 -0.20 (-0.53%)
As of: Sep 9, 2026 · 2:26 PM EDT

Harrow (HROW) Operating Income (2010 - 2026)

Harrow (HROW) posted Operating Income of -$11.0 million for Q2 2026, up 50.15% on a QoQ basis from -$22.1 million in Q1 2026, and down 196.48% year-over-year from $11.4 million in Q2 2025.

Analysis

Harrow (HROW) Operating Income (2010 - 2026) Analysis & Trends

Harrow has reported Operating Income for 17 years, with the latest figure at -$11.0 million in Q2 2026.

  • On a quarterly basis, Operating Income fell 196.48% year-over-year to -$11.0 million in Q2 2026; TTM through Jun 2026 was -$2.7 million, a 119.09% decrease from a year earlier, with the FY2025 full-year figure at $30.5 million, up 245.9% from the prior year.
  • Operating Income was -$11.0 million for Q2 2026 at Harrow, up from -$22.1 million in the prior quarter.
  • The five-year high for Operating Income was $15.6 million in Q4 2025, with the low at -$22.1 million in Q1 2026.
  • Average Operating Income over 5 years is $477777.8, with a median of $1.4 million recorded in 2024.
  • The sharpest annual moves came in 2023 and 2024: Operating Income soared 1955.32% in 2023, then sank 672.56% in 2024.
  • Over 5 years, Operating Income stood at -$1.8 million in 2022, then plunged by 174.18% to -$4.9 million in 2023, then soared by 364.59% to $12.9 million in 2024, then rose by 20.87% to $15.6 million in 2025, then tumbled by 170.6% to -$11.0 million in 2026.
  • The last three Operating Income figures came in at -$11.0 million (Q2 2026), -$22.1 million (Q1 2026), and $15.6 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc (Qtr)
1 Johnson & Johnson 646.71 Bn 625.95 Bn 17.26 Bn 7.14 Bn
2 AbbVie 442.22 Bn 435.65 Bn 12.70 Bn 6.43 Bn
3 Merck 366.92 Bn 359.78 Bn 12.21 Bn -584.00 Mn
4 Novartis Ag 266.90 Bn 259.21 Bn 11.24 Bn 4.75 Bn
5 Pfizer 159.20 Bn 147.50 Bn 10.94 Bn 4.27 Bn
6 Sanofi 52.44 Bn 45.06 Bn 10.79 Bn 1.22 Bn
7 Revolution Medicines 44.11 Bn 44.11 Bn - -505.13 Mn
8 Incyte 25.38 Bn 20.85 Bn 1.57 Bn 697.90 Mn
9 United Therapeutics 21.50 Bn 18.84 Bn 683.80 Mn 330.80 Mn
10 Harrow 1.41 Bn 1.32 Bn 50.36 Mn -11.01 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -11.01 Mn
Mar 31, 2026 -22.08 Mn
Dec 31, 2025 15.59 Mn
Sep 30, 2025 14.75 Mn
Jun 30, 2025 11.41 Mn
Mar 31, 2025 -11.23 Mn
Dec 31, 2024 12.90 Mn
Sep 30, 2024 1.32 Mn
Jun 30, 2024 1.53 Mn
Mar 31, 2024 -6.93 Mn
Dec 31, 2023 -4.88 Mn
Sep 30, 2023 1.74 Mn
Jun 30, 2023 2.35 Mn
Mar 31, 2023 1.21 Mn
Dec 31, 2022 -1.78 Mn
Sep 30, 2022 -94,000.00
Jun 30, 2022 1.69 Mn
Mar 31, 2022 2.10 Mn
Dec 31, 2021 -1.76 Mn
Sep 30, 2021 -3.72 Mn